The Centers for Disease Control and Prevention released a video explaining the risks and benefits of vaccines used to prevent severe respiratory illness [1].
This guidance is critical because it aims to help the public make informed medical decisions to reduce the overall burden of severe respiratory infections in the U.S. By balancing potential side effects against the protection offered by immunization, the agency seeks to increase public health literacy.
The CDC said that vaccines can significantly lower the risk of severe respiratory illness [1]. While the agency acknowledged that vaccines may have potential side effects, it said the necessity of weighing these against the dangers of the viruses themselves is important [1].
Recent data highlighted in the communication show strong protection provided by these vaccines [1]. The agency said that the protection is especially strong against Respiratory Syncytial Virus, commonly known as RSV [1].
Public health officials said the goal of this transparency is to allow individuals to understand the risk-benefit perspective [1]. This approach is designed to ensure that patients and providers can discuss the specific needs of high-risk populations, such as the elderly or immunocompromised, while considering the efficacy of current vaccine formulations [1].
The agency's communication underscores a broader effort to maintain vaccination rates by providing a nuanced view of medical interventions [1]. By addressing both the benefits and the risks, the CDC said it aims to build trust with a public that may have concerns regarding vaccine safety [1].
“Vaccines can lower the risk of severe respiratory illness.”
The CDC's shift toward a transparent risk-benefit framework reflects a strategy to combat vaccine hesitancy. By explicitly acknowledging side effects while highlighting the high efficacy against RSV, the agency is attempting to move from a mandate-style communication to a shared-decision making model between patients and healthcare providers.
